Biocartis Group NV provided earnings guidance for the year 2022. For the year, the company expects to Grow product revenue by 24-36% to between EUR 50 million and EUR 55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 EUR | +1.05% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.14M | |
+72.58% | 12.32B | |
-18.04% | 7.96B | |
+3.57% | 5.84B | |
+6.65% | 5.11B | |
+20.83% | 4.28B | |
-19.57% | 4B | |
-41.19% | 2.15B | |
+0.25% | 2.01B | |
+4.02% | 1.8B |
- Stock Market
- Equities
- BCART Stock
- News Biocartis Group NV
- Biocartis Group NV Provides Earnings Guidance for the Year 2022